ICON Public Limited (ICLR)
NASDAQ: ICLR
· Real-Time Price · USD
140.82
-2.20 (-1.54%)
At close: May 05, 2025, 3:59 PM
-1.54% (1D)
| Bid | 101.52 |
| Market Cap | 11.37B |
| Revenue (ttm) | 8.19B |
| Net Income (ttm) | 758.19M |
| EPS (ttm) | 9.18 |
| PE Ratio (ttm) | 15.34 |
| Forward PE | 9.13 |
| Analyst | Buy |
| Ask | 180.48 |
| Volume | 124,879 |
| Avg. Volume (20D) | 1,355,158 |
| Open | 143.18 |
| Previous Close | 143.02 |
| Day's Range | 140.00 - 143.18 |
| 52-Week Range | 133.28 - 347.72 |
| Beta | 1.23 |
About ICLR
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, incl...
Industry Medical - Diagnostics & Research
Sector Healthcare
IPO Date May 15, 1998
Employees 41,250
Stock Exchange NASDAQ
Ticker Symbol ICLR
Website https://www.iconplc.com
Analyst Forecast
According to 12 analyst ratings, the average rating for ICLR stock is "Buy." The 12-month stock price forecast is $180, which is an increase of 27.82% from the latest price.
Stock Forecasts4 days ago
-4.11%
Icon shares are trading lower after the company re...
Unlock content with
Pro Subscription
4 days ago
+1.43%
Icon shares are trading lower after the company reported worse-than-expected Q1 sales results.
5 days ago · businesswire.com
ICON Reports First Quarter 2025 ResultsDUBLIN--(BUSINESS WIRE)--ICON Reports First Quarter 2025 Results.
